Health+Benefits

Understanding the many risks of alternative funding and importation of specialty drugs.

Q&A with Dr. Christine Hale, Chief Medical Officer, U.S. Benefits, Gallagher, and Dr. David Debono, Oncology Medical Director, Carelon Health

As Democrats eye retaking control of one or both chambers of Congress, they could bring the next major battle over health insurance with them.

Year-round education on preventive care and network value reduces employee costs and increases satisfaction.